CD47型
抗体调理
单克隆抗体
巨噬细胞
吞噬作用
生物
癌症研究
抗体
癌细胞
免疫疗法
癌症免疫疗法
封锁
免疫学
癌症
调理素
免疫系统
受体
体外
生物化学
遗传学
作者
Lawrence J. Dooling,Jason C. Andrechak,Brandon H. Hayes,Siddhant Kadu,Wei Zhang,Ruby Pan,Manasvita Vashisth,Jerome Irianto,Cory Alvey,Leyuan Ma,Dennis E. Discher
标识
DOI:10.1038/s41551-023-01031-3
摘要
In solid tumours, the abundance of macrophages is typically associated with a poor prognosis. However, macrophage clusters in tumour-cell nests have been associated with survival in some tumour types. Here, by using tumour organoids comprising macrophages and cancer cells opsonized via a monoclonal antibody, we show that highly ordered clusters of macrophages cooperatively phagocytose cancer cells to suppress tumour growth. In mice with poorly immunogenic tumours, the systemic delivery of macrophages with signal-regulatory protein alpha (SIRPα) genetically knocked out or else with blockade of the CD47–SIRPα macrophage checkpoint was combined with the monoclonal antibody and subsequently triggered the production of endogenous tumour-opsonizing immunoglobulin G, substantially increased the survival of the animals and helped confer durable protection from tumour re-challenge and metastasis. Maximizing phagocytic potency by increasing macrophage numbers, by tumour-cell opsonization and by disrupting the phagocytic checkpoint CD47–SIRPα may lead to durable anti-tumour responses in solid cancers. Durable anti-tumour responses can be triggered by maximizing the cooperative phagocytic potency of macrophages through the disruption of the CD47–SIRPα macrophage checkpoint and by delivering a tumour-opsonizing monoclonal antibody.
科研通智能强力驱动
Strongly Powered by AbleSci AI